Literature DB >> 3091381

Differentiation antigens on rhesus monkey lymphocytes. II. Characterization of RhT3, a CD3-like antigen on T cells.

F J Nooij, M Jonker, H Balner.   

Abstract

A monoclonal antibody FN18 is described, which is specific for mature rhesus monkey T lymphocytes. It defines a cell surface antigen, composed of two polypeptide chains with a molecular mass of 22 and 27 kDa. In view of these and other similarities with the human T3 or CD3 antigen, it was designated as RhT3. Expression, distribution and certain functions of RhT3 were compared with those of its human counterpart. Analogous to anti-CD3 antibodies in man, FN18 is able to modulate its target antigen, has mitogenic properties and is able to block the pokeweed mitogen and concanavalin A-driven cell proliferation, but not that caused by phytohemagglutinin. In spite of such minor dissimilarities the available data strongly suggest that the RhT3 antigen is the rhesus monkey's homologue of the human CD3 antigen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091381     DOI: 10.1002/eji.1830160818

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques.

Authors:  E MeinL; R M Hoch; K Dornmair; R de Waal Malefyt; R E Bontrop; M Jonker; H Lassmann; R Hohlfeld; H Wekerle; B A 't Hart
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Polymorphism for RhT3, a CD3-like cell surface antigen, expressed on rhesus monkey T lymphocytes.

Authors:  F J Nooij; W van Vreeswijk; J Coolen
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

3.  A monoclonal antibody selection for immunohistochemical examination of lymphoid tissues from non-human primates.

Authors:  Yolanda S Kap; Marjan van Meurs; Nikki van Driel; Gerrit Koopman; Marie-Jose Melief; Herbert P M Brok; Jon D Laman; Bert A 't Hart
Journal:  J Histochem Cytochem       Date:  2009-09-03       Impact factor: 2.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.